Ozempic vs. Wegovy: What's the Difference?

Walk into almost any conversation about weight loss medication and Ozempic comes up. But you may have also heard of Wegovy — and wondered if they're the same thing or completely different.

The short answer: they both contain semaglutide. But they're approved for different conditions, come in different doses, and have some meaningful differences you should understand before asking your doctor about either one.

Same Active Ingredient, Different Doses

Both Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist. They're both made by the same manufacturer (Novo Nordisk) and work through the same mechanism: binding to GLP-1 receptors in the brain and gut to reduce appetite and regulate blood sugar.

The key difference is in the approved maximum dose:

| | Ozempic | Wegovy |

|---|---|---|

| Active ingredient | Semaglutide | Semaglutide |

| Approved for | Type 2 diabetes | Chronic weight management |

| Max approved dose | 2 mg/week | 2.4 mg/week |

| How it's given | Weekly injection | Weekly injection |

Both are once-weekly subcutaneous injections (under the skin, typically in the abdomen, thigh, or upper arm).

Different FDA Approvals for Different Conditions

Ozempic was approved to improve blood sugar control in adults with type 2 diabetes, and to reduce cardiovascular risk in those with established heart disease — an indication supported by [the SUSTAIN-6 trial, which showed semaglutide 0.5 or 1.0 mg weekly reduced major adverse cardiovascular events in T2DM (HR 0.74, P<0.001 for noninferiority and P=0.02 for superiority)](https://pubmed.ncbi.nlm.nih.gov/27633186/). Weight loss is a well-documented effect, but it's not the official indication.

Wegovy was approved specifically for chronic weight management in adults with:

• BMI ≥ 30 (obesity), or
• BMI ≥ 27 (overweight) with at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol

Why "Off-Label" Ozempic Became So Common

Because Ozempic was available before Wegovy, and because many people without diabetes experienced significant weight loss on it, physicians began prescribing Ozempic off-label for weight loss. Off-label prescribing is legal and common in medicine — physicians are permitted to prescribe an approved drug for conditions beyond its official approval.

When Wegovy faced supply shortages (which happened significantly in 2022-2023), many patients on Wegovy were switched back to Ozempic at whatever dose was available.

Does the 0.4mg Dose Difference Matter?

[The STEP 1 trial of semaglutide 2.4 mg/week in adults with overweight or obesity (without diabetes) found mean weight loss of about 14.9% versus 2.4% with placebo at 68 weeks](https://pubmed.ncbi.nlm.nih.gov/33567185/). Ozempic trials (which focused on diabetes) used lower doses and showed less weight loss.

Some evidence suggests the higher Wegovy dose produces meaningfully better weight loss outcomes — though individuals vary considerably in response. Not everyone needs the maximum dose to see good results.

What About Cost and Insurance?

This is where it gets complicated. Wegovy is more commonly covered by insurance for weight management than Ozempic is (when prescribed off-label for weight loss). But coverage depends heavily on your specific plan.

Both medications are expensive without insurance — typically several hundred dollars per month. The landscape of coverage, manufacturer savings cards, and compounded alternatives changes frequently, which is something to discuss with your prescribing physician.

The Bottom Line

If you're managing type 2 diabetes, Ozempic is the appropriate on-label choice. If you're seeking weight management and don't have diabetes, Wegovy is the on-label option — and the dose approved for weight loss is slightly higher.

Both are effective. The right one for you depends on your health history, insurance coverage, and what your physician recommends based on your full picture.

Ready to talk to a real doctor? Get started with Coral Health today.